Coding

Part:BBa_K3142005:Design

Designed by: Luo Xiaolin   Group: iGEM19_SZPT-CHINA   (2019-10-13)
Revision as of 22:09, 20 October 2019 by Xiaolin (Talk | contribs) (→‎Design Notes)


Antihypertensive dipeptide（VY）


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.

Source

no

References